Clinical Trial Update: Effect of Sacubitril-Valsartan on Cardiac Structure and Function [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial led by Mayo Clinic is evaluating the effect of sacubitril-valsartan on cardiac structure and function in individuals with congenital he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Mayo Clinic | Conditions: Congenital Heart Disease | Phase 3 | Status: RECRUITING